NCT00667108View on ClinicalTrials.gov

A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

PHASE3CompletedINTERVENTIONAL
Enrollment

784

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

January 31, 2005

Conditions
Transient Insomnia
Interventions
DRUG

Gabapentin

Gabapentin 250 mg oral capsule 30 minutes prior to bedtime

DRUG

Gabapentin

Gabapentin 500 mg oral capsule 30 minutes prior to bedtime

DRUG

Placebo

Matched placebo 30 minutes prior to bedtime

Trial Locations (8)

29307

Pfizer Investigational Site, Spartanburg

32809

Pfizer Investigational Site, Orlando

45219

Pfizer Investigational Site, Cincinnati

75235

Pfizer Investigational Site, Dallas

83704

Pfizer Investigational Site, Boise

92121

Pfizer Investigational Site, San Diego

92801

Pfizer Investigational Site, Anaheim

08054

Pfizer Investigational Site, Mount Laurel

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00667108 - A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Biotech Hunter | Biotech Hunter